Home > Insider Trading > Filing (0001209191-18-046311)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368148	Athersys Inc / New	ATHX	Pharmaceutical Preparations (2834)	204864095

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1402605	K Laura Campbell	3201 Carnegie Avenue Cleveland OH 44115-2634	Senior Vice Pres Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-08-08	2,800	$2.01	590,424	No	4	S	Direct
Common Stock	Disposition	2018-08-09	1,000	$2.00	589,424	No	4	S	Direct
Common Stock	Disposition	2018-08-10	25,068	$2.01	564,356	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.015, inclusive.
Securities beneficially owned are comprised of: (1) 423,755 shares of common stock owned and (2) unvested restricted stock units aggregating 140,601 related to annual awards, which vest quarterly over a four-year period from grant date.